Interindividual variation in the metabolism of arsenic in cultured primary human hepatocytes

被引:77
作者
Drobná, Z
Waters, SB
Walton, FS
LeCluyse, EL
Thomas, DJ
Styblo, M
机构
[1] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Med, Curriculum Toxicol, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Sch Pharm, Div Drug Delivery & Disposit, Chapel Hill, NC 27599 USA
[4] US EPA, Pharmacokinet Branch, Expt Toxicol Branch,Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA
基金
美国国家卫生研究院;
关键词
arsenic; metabolism; methylation; variation; human; hepatocyte; cyt19;
D O I
10.1016/j.taap.2004.05.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Liver is a prime site for conversion of inorganic arsenic (iAs) to methylated metabolites, including methylarsenicals (MAs) and dimethylarsenicals (DMAs). To assess interindividual variation in the capacity of liver to metabolize iAs, we examined the metabolic fate of arsenite (iAs(III)) in normal primary human hepatocytes obtained from eight donors and cultured under standard conditions. Methylation rates, yields, and distribution of arsenicals were determined for hepatocytes exposed to 0.3-30 nmol of iAs(III)/mg of protein for 24 h. Although the accumulation of arsenic (As) by cells was a linear function of the initial concentration of iAs(III) in culture, the concentration of As retained in cells varied several fold among donors. DMAs was the major methylated metabolite found in cultures exposed to low concentrations of iAs l; at higher concentrations, MAs was always predominant. Maximal rates for methylation of iAs(III) were usually attained at 3 or 9 nmol of iA(III)/mg of protein and varied about 7-fold among donors. For most donors, the methylation rate decreased at the highest iAs(III) concentrations. MAs was the major methylated metabolite retained in cells regardless of exposure level. DMAs was the major methylated metabolite found in medium. The interindividual differences in rates for iAs(III) methylation were not strictly associated with variations in basal mRNA levels for cyt19, an As-methyltransferase. Analysis of the coding sequence of cytl9 identified one heterozygote with Met287Thr mutation in a single allele. Thus, genetic polymorphism of cyt19 along with other cellular factors is likely responsible for interindividual differences in the capacity of primary human hepatocytes to retain and metabolize iAs (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:166 / 177
页数:12
相关论文
共 51 条
[1]  
AEBI H, 1984, METHOD ENZYMOL, V105, P121
[2]  
ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548
[3]  
[Anonymous], 2001, Arsenic in Drinking Water
[4]   ARSENIC BINDING-PROTEINS OF MAMMALIAN SYSTEMS .1. ISOLATION OF 3 ARSENITE-BINDING PROTEINS OF RABBIT LIVER [J].
BOGDAN, GM ;
SAMPAYOREYES, A ;
APOSHIAN, HV .
TOXICOLOGY, 1994, 93 (2-3) :175-193
[5]   THE INFLUENCE OF LIVER-DISEASE ON THE METHYLATION OF ARSENITE IN HUMANS [J].
BUCHET, JP ;
GEUBEL, A ;
PAUWELS, S ;
MAHIEU, P ;
LAUWERYS, R .
ARCHIVES OF TOXICOLOGY, 1984, 55 (03) :151-154
[6]   Aquaglyceroporin AQP9: Solute permeation and metabolic control of expression in liver [J].
Carbrey, JM ;
Gorelick-Feldman, DA ;
Kozono, D ;
Praetorius, J ;
Nielsen, S ;
Agre, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) :2945-2950
[7]  
CORNISHBOWDEN A, 1995, FUNDAMENTALS ENZYME, P100
[8]   THE REACTION OF METHYLARSENICALS WITH THIOLS - SOME BIOLOGICAL IMPLICATIONS [J].
CULLEN, WR ;
MCBRIDE, BC ;
REGLINSKI, J .
JOURNAL OF INORGANIC BIOCHEMISTRY, 1984, 21 (03) :179-194
[9]   REDUCTION AND BINDING OF ARSENATE AND DIMETHYLARSINATE BY GLUTATHIONE - A MAGNETIC-RESONANCE STUDY [J].
DELNOMDEDIEU, M ;
BASTI, MM ;
OTVOS, JD ;
THOMAS, DJ .
CHEMICO-BIOLOGICAL INTERACTIONS, 1994, 90 (02) :139-155
[10]   TRANSFER OF ARSENITE FROM GLUTATHIONE TO DITHIOLS - A MODEL OF INTERACTION [J].
DELNOMDEDIEU, M ;
BASTI, MM ;
OTVOS, JD ;
THOMAS, DJ .
CHEMICAL RESEARCH IN TOXICOLOGY, 1993, 6 (05) :598-602